Proportion of TLR-9 Gene Polymorphisms at rs352139 (G1174A) in HIV/AIDS Patients in West Java, Indonesia

Authors

  • Yehezkiel Yonathan Padjadjaran University image/svg+xml
  • Edhyana Sahiratmadja 2Department of Biomedical Sciences Faculty of Medicine Universitas Padjadjaran
  • Agnes Rengga Indrati Department of Clinical Pathology Faculty of Medicine Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital Bandung

DOI:

https://doi.org/10.15850/amj.v7n.2014

Keywords:

CD4 , HIV/AIDS, polymorphisms, rapid progression, TLR-9, West Java

Abstract

Background: Human immunodeficiency virus (HIV) infection is the main cause of the immunodeficiency syndrome (AIDS). TLR-9 gene encodes a toll-like receptor-9 that plays a key role in innate immunity. This study aimed to describe the proportion of TLR-9 polymorphisms at rs352139 in patients with human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) in Bandung, West Java, Indonesia.

Methods: This was a descriptive study involving a total of 96 patients with HIV/AIDS treated in a tertiary hospital in Bandung, West Java, Indonesia in 2013. TLR-9 gene polymorphisms at rs 352139 were examined using a mass screening platform and the genotypes proportion was presented in percentage and compared with other populations.

Results: The average age of the HIV/AIDS patients recruited was 30 years (SD+6.1) and the baseline mean of CD4+ count was 318.02 mm3 (Normal was 1,500 mm3) (SD+273.1). The proportion of polymorphisms at rs352139or G1174A presented a wild type genotype GG (42.7%), GA (44.9%), and AA (12.4%), resulting in a total proportion nucleotide change of 57.3%.

Conclusion: A total proportion of nucleotide change or polymorphisms is higher than the wild type. A further cohort study is of great interest to associate the rs352139 polymorphisms with a decrease in CD4+cells in HIV/AIDS patients, confirming a rapid disease progression.

 

Author Biography

  • Yehezkiel Yonathan, Padjadjaran University
    -

References

Sharp PM, Hahn BH. Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med. 2011;1:1.

UNAIDS. UNAIDS Data 2017. 2017;

Ditjen PP & PL Kemenkes RI, Kementrian Kesehatan RI. Data Statistik HIV di Indonesia 2014. Kemenkes RI. 2014: 1–3.

Siliciano RF, Greene WC. HIV latency. Cold Spring Harb Perspect Med. 2011;1(1):a007096.

Nicholas JB, Shelley AG, Michael SB, Aaron G, Mary LWP. HIV Infection and AIDS Workup. Medscape. 2017.

Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013;382: 1525-1533.

Maartens G, Celum C, Lewin SR. HIV infection: Epidemiology, pathogenesis, treatment, and prevention. Lancet. 2014;384: 258-271.

MacKelprang RD, Bigham AW, Celum C, DeBruyn G , Beima-Sofie K, John-Stewart G. Toll-like receptor polymorphism associations with HIV-1 outcomes among sub-saharan Africans. J Infect Dis. 2014;209:1623–7.

Hajishengallis G, Lambris JD. More than complementing Tolls: Complement–Toll-like receptor synergy and crosstalk in innate immunity and inflammation. Immunol Rev. 2017; 274(1): 233–244.

Skevaki C, Pararas M, Kostelidou K, Tsakris A, Routsias JG. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious diseases. Clin Exp Immunol. 2015;180:165–77.

Willie B, Hall NB, Stein CM, Jurevic RJ, Weinberg A, Mehlotra RK, Zimmerman PA..Association of Toll-Like Receptor Polymorphisms With HIV Status in North Americans. Genes Immun. 2015;15:569–77.

Brichacek B, Vanpouille C, Kiselyeva Y, Biancotto A, Merbah M, Hirsch I. Contrasting roles for TLR ligands in HIV-1 pathogenesis. PLoS One. 2010:1–12.

Kobayashi K, Yuliwulandari R, Yanai H, Naka I, Lien LT, Hang NT. Association of TLR Polymorphisms with Development of Tuberculosis in Indonesian Females. Tissue Antigens. 2012;79:190–7.

Yang Y, Li X, Cui W, Guan L, Shen F, Xu J. Potential association of pulmonary tuberculosis with genetic polymorphisms of toll-like receptor 9 and interferon-gamma in a Chinese population. BMC Infect Dis. 2013;13:511.

Torres-Garcia D, Cruz-Lagunas A, Garcia-Sancho FMC, Fernandez-Plata R, Baez-Saldana R, Mendoza-Milla C. Variants in toll-like receptor 9 gene influence susceptibility to tuberculosis in a Mexican population. J Transl Med. 2013;11:220.

Kementrian Kesehatan Republik Indonesia. Pedoman Nasional Tatalaksana Klinis Infeksi HIV dan Terapi Antiretroviral Pada Orang Dewasa. 2011;

Liovat AS, Rey-Cuille MA, Lecuroux C, Jacquelin B, Girault I PG, et al. Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection. PLoS One. 2012;7(10):e46143.

Joshi A, Punke EB, Mehmetoglu-gurbuz T, Peralta DP, Garg H. TLR9 polymorphism correlates with immune activation , CD4 decline and plasma IP10 levels in HIV patients.BMC Infectious Disease. 2019;1–13.

Downloads

Published

2020-12-31

Issue

Vol. 7 No. 4 (2020)

Section

Articles

License

  1. Authors retain copyright and grant Althea Medical Journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to freely share and remix the work with an acknowledgement of the work's authorship and initial publication in Althea Medical Journal. Althea Medical Journal is licensed under CC BY-NC 4.0
  2. Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Althea Medical Journal.